Compare Medtronic PLC (MDT) vs Roundhill Innov-100 0DTE Covered Call Strat ETF (QDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Roundhill Innov-100 0DTE Covered Call Strat ETF — how do they compare? Medtronic PLC trades at $82.86 (market cap $106.61B), while Roundhill Innov-100 0DTE Covered Call Strat ETF trades at $29.6. The key difference: Medtronic PLC pays a 3.46% dividend while Roundhill Innov-100 0DTE Covered Call Strat ETF pays none. Which is the better fit depends on your goals.
| MDT | QDTE | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $105.35 | $36.60 |
52-Week Low | $73.75 | $26.85 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
QDTE (Roundhill Innovation-100 0DTE Covered Call Strategy ETF) trades at $29.22, up 0.31% on the day, while technical indicators signal a bearish trend with strong sell signals from moving averages. The ETF generates weekly dividends, with recent payouts ranging from $0.12 to $0.28, but financial ratios like P/E and P/S are unavailable. News highlights focus on its high distribution yield amid declining volatility, with comparisons to peers like XDTE.
Outlook remains cautious due to bearish technicals and fee concerns, though the weekly income strategy appeals to yield-seeking investors. Risks include sensitivity to market volatility and competitive pressure from other income ETFs. Investors should weigh the high yield against potential capital erosion from covered call strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Roundhill Innov-100 0DTE Covered Call Strat ETF
QDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the NASDAQ 100. It primarily holds a portfolio of U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the NASDAQ 100. This highly tactical strategy aims to maximize option premium capture by exploiting the rapid time decay of options expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on QDTE →
